The Veeda Newsletter

April 2017

Industry growth drivers

• Pharma Profits Continue to Dwarf R&D Spending as Pressure Mounts  Read More
• Analysts unpack CRO market Expectations  Read More
• 5 trends changing clinical trials  Read More
• More than half of patients’ out-of-pocket spending for brand medicines is based on full list price  Read More
• The U.S. Burden of Neurological Disease is nearly $800 Billion/Year According to New American Neurological Association Study   Read More

Clinical Research and Clinical Trials

• FDA approves first-in-human trial for neural-enabled prosthetic hand system developed at FIU  Read More
• Galapagos Initiates Phase 1 Trial of New Therapy for CF Treatment  Read More
• Sun Bio-Pharma Provides Phase 1 Trial Update; Patients Experience Early Signs of Efficacy  Read More
• Racing in lung cancer again (or still), Merck and BMS expand Incyte combo trials  Read More

Newsmakers

• AstellasPharma has agreed to acquire privately-held Belgian drug discovery group Odega in a deal worth up to 800 million Euros.  Read More
• Pharma warns new NICE rules will delay access to meds  Read More
• Qiagen joins CANCERID, a PPP blood based biomarkers consortium aims to standardize & clinically validate  Read More

Fact sheet

• BMS’ Opdivo shown to improve five-year lung cancer survival  Read More
• Pharma's digital revolution turns to Austin as Merck eyes sites for 600-person IT hub  Read More
• National agency pushback against EMA fast track continues  Read More

Clinical research, Clinical trials and Research Grants

• FDA posts briefing materials prior to Advisory Committee meeting for nonacog beta pegol, a long-acting factor IX for the treatment of haemophilia B  Read More
• Once-weekly Semaglutide Demonstrated Consistent Blood Glucose Reductions and Weight Loss Regardless of Background Oral Antidiabetic Treatment   Read More
• Midtown Medical Center announces diabetes drug grant from Johnson and Johnson  Read More

Compliance , Rules , Regulations , Guidelines

• Hospital majors see National Health Policy& Mental Health Billas paradigm shift in patient services  Read More
• DCGI directs state drug controllers to strictly control manufacture, sale & distribution of oxytocin   Read More
• Six new medicines backed for EU approval  Read More
• Asia Regulatory Roundup  Read More
• FDA Unveils Regulatory Science Progress Report.  Read More
• Priority Review Drugs Have Higher Likelihood of Getting Boxed Warning After Approval.  Read More

Upcoming Conferences and Events

Veeda Clinical Research will be participating in the CPhI north America Conference on May 16-18, 2017 Pennsylvania Convention Center Philadelphia, PA, USA